Cargando…

Molecular characterization of invasive capsule null Neisseria meningitidis in South Africa

BACKGROUND: The meningococcal capsule is an important virulence determinant. Unencapsulated meningococci lacking capsule biosynthesis genes and containing the capsule null locus (cnl) are predominantly non-pathogenic. Rare cases of invasive meningococcal disease caused by cnl isolates belonging to s...

Descripción completa

Detalles Bibliográficos
Autores principales: Ganesh, Karistha, Allam, Mushal, Wolter, Nicole, Bratcher, Holly B., Harrison, Odile B., Lucidarme, Jay, Borrow, Ray, de Gouveia, Linda, Meiring, Susan, Birkhead, Monica, Maiden, Martin C. J., von Gottberg, Anne, du Plessis, Mignon
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5320719/
https://www.ncbi.nlm.nih.gov/pubmed/28222677
http://dx.doi.org/10.1186/s12866-017-0942-5
_version_ 1782509591606591488
author Ganesh, Karistha
Allam, Mushal
Wolter, Nicole
Bratcher, Holly B.
Harrison, Odile B.
Lucidarme, Jay
Borrow, Ray
de Gouveia, Linda
Meiring, Susan
Birkhead, Monica
Maiden, Martin C. J.
von Gottberg, Anne
du Plessis, Mignon
author_facet Ganesh, Karistha
Allam, Mushal
Wolter, Nicole
Bratcher, Holly B.
Harrison, Odile B.
Lucidarme, Jay
Borrow, Ray
de Gouveia, Linda
Meiring, Susan
Birkhead, Monica
Maiden, Martin C. J.
von Gottberg, Anne
du Plessis, Mignon
author_sort Ganesh, Karistha
collection PubMed
description BACKGROUND: The meningococcal capsule is an important virulence determinant. Unencapsulated meningococci lacking capsule biosynthesis genes and containing the capsule null locus (cnl) are predominantly non-pathogenic. Rare cases of invasive meningococcal disease caused by cnl isolates belonging to sequence types (ST) and clonal complexes (cc) ST-845 (cc845), ST-198 (cc198), ST-192 (cc192) and ST-53 (cc53) have been documented. The clinical significance of these isolates however remains unclear. We identified four invasive cnl meningococci through laboratory-based surveillance in South Africa from 2003 through 2013, which we aimed to characterize using whole genome data. RESULTS: One isolate [NG: P1.7-2,30: F1-2: ST-53 (cc53)] contained cnl allele 12, and caused empyema in an adult male with bronchiectasis from tuberculosis, diabetes mellitus and a smoking history. Three isolates were NG: P1.18-11,42-2: FΔ: ST-192 (cc192) and contained cnl allele 2. One patient was an adolescent male with meningitis. The remaining two isolates were from recurrent disease episodes (8 months apart) in a male child with deficiency of the sixth complement component, and with the exception of two single nucleotide polymorphisms, contained identical core genomes. The ST-53 (cc53) isolate possessed alleles for NHBA peptide 191 and fHbp variant 2; whilst the ST-192 (cc192) isolates contained NHBA peptide 704 and fHbp variant 3. All four isolates lacked nadA. Comparison of the South African genomes to 61 additional cnl genomes on the PubMLST Neisseria database (http://pubmlst.org/neisseria/), determined that most putative virulence genes could be found in both invasive and carriage phenotypes. CONCLUSIONS: Although rare, invasive disease by cnl meningococci may be associated with host immunodeficiency and such patients may benefit from protein-based meningococcal vaccines. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s12866-017-0942-5) contains supplementary material, which is available to authorized users.
format Online
Article
Text
id pubmed-5320719
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-53207192017-02-24 Molecular characterization of invasive capsule null Neisseria meningitidis in South Africa Ganesh, Karistha Allam, Mushal Wolter, Nicole Bratcher, Holly B. Harrison, Odile B. Lucidarme, Jay Borrow, Ray de Gouveia, Linda Meiring, Susan Birkhead, Monica Maiden, Martin C. J. von Gottberg, Anne du Plessis, Mignon BMC Microbiol Research Article BACKGROUND: The meningococcal capsule is an important virulence determinant. Unencapsulated meningococci lacking capsule biosynthesis genes and containing the capsule null locus (cnl) are predominantly non-pathogenic. Rare cases of invasive meningococcal disease caused by cnl isolates belonging to sequence types (ST) and clonal complexes (cc) ST-845 (cc845), ST-198 (cc198), ST-192 (cc192) and ST-53 (cc53) have been documented. The clinical significance of these isolates however remains unclear. We identified four invasive cnl meningococci through laboratory-based surveillance in South Africa from 2003 through 2013, which we aimed to characterize using whole genome data. RESULTS: One isolate [NG: P1.7-2,30: F1-2: ST-53 (cc53)] contained cnl allele 12, and caused empyema in an adult male with bronchiectasis from tuberculosis, diabetes mellitus and a smoking history. Three isolates were NG: P1.18-11,42-2: FΔ: ST-192 (cc192) and contained cnl allele 2. One patient was an adolescent male with meningitis. The remaining two isolates were from recurrent disease episodes (8 months apart) in a male child with deficiency of the sixth complement component, and with the exception of two single nucleotide polymorphisms, contained identical core genomes. The ST-53 (cc53) isolate possessed alleles for NHBA peptide 191 and fHbp variant 2; whilst the ST-192 (cc192) isolates contained NHBA peptide 704 and fHbp variant 3. All four isolates lacked nadA. Comparison of the South African genomes to 61 additional cnl genomes on the PubMLST Neisseria database (http://pubmlst.org/neisseria/), determined that most putative virulence genes could be found in both invasive and carriage phenotypes. CONCLUSIONS: Although rare, invasive disease by cnl meningococci may be associated with host immunodeficiency and such patients may benefit from protein-based meningococcal vaccines. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s12866-017-0942-5) contains supplementary material, which is available to authorized users. BioMed Central 2017-02-21 /pmc/articles/PMC5320719/ /pubmed/28222677 http://dx.doi.org/10.1186/s12866-017-0942-5 Text en © The Author(s). 2017 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research Article
Ganesh, Karistha
Allam, Mushal
Wolter, Nicole
Bratcher, Holly B.
Harrison, Odile B.
Lucidarme, Jay
Borrow, Ray
de Gouveia, Linda
Meiring, Susan
Birkhead, Monica
Maiden, Martin C. J.
von Gottberg, Anne
du Plessis, Mignon
Molecular characterization of invasive capsule null Neisseria meningitidis in South Africa
title Molecular characterization of invasive capsule null Neisseria meningitidis in South Africa
title_full Molecular characterization of invasive capsule null Neisseria meningitidis in South Africa
title_fullStr Molecular characterization of invasive capsule null Neisseria meningitidis in South Africa
title_full_unstemmed Molecular characterization of invasive capsule null Neisseria meningitidis in South Africa
title_short Molecular characterization of invasive capsule null Neisseria meningitidis in South Africa
title_sort molecular characterization of invasive capsule null neisseria meningitidis in south africa
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5320719/
https://www.ncbi.nlm.nih.gov/pubmed/28222677
http://dx.doi.org/10.1186/s12866-017-0942-5
work_keys_str_mv AT ganeshkaristha molecularcharacterizationofinvasivecapsulenullneisseriameningitidisinsouthafrica
AT allammushal molecularcharacterizationofinvasivecapsulenullneisseriameningitidisinsouthafrica
AT wolternicole molecularcharacterizationofinvasivecapsulenullneisseriameningitidisinsouthafrica
AT bratcherhollyb molecularcharacterizationofinvasivecapsulenullneisseriameningitidisinsouthafrica
AT harrisonodileb molecularcharacterizationofinvasivecapsulenullneisseriameningitidisinsouthafrica
AT lucidarmejay molecularcharacterizationofinvasivecapsulenullneisseriameningitidisinsouthafrica
AT borrowray molecularcharacterizationofinvasivecapsulenullneisseriameningitidisinsouthafrica
AT degouveialinda molecularcharacterizationofinvasivecapsulenullneisseriameningitidisinsouthafrica
AT meiringsusan molecularcharacterizationofinvasivecapsulenullneisseriameningitidisinsouthafrica
AT birkheadmonica molecularcharacterizationofinvasivecapsulenullneisseriameningitidisinsouthafrica
AT maidenmartincj molecularcharacterizationofinvasivecapsulenullneisseriameningitidisinsouthafrica
AT vongottberganne molecularcharacterizationofinvasivecapsulenullneisseriameningitidisinsouthafrica
AT duplessismignon molecularcharacterizationofinvasivecapsulenullneisseriameningitidisinsouthafrica